On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Myeloma Patients Europe AISBL's own share of each project, not the project's full budget.
- Horizon Europe€459k · 3 projects
- Horizon 2020€164k · 3 projects
Projects
6 EU-funded projects, newest first. Each links to the official record.
- iN-KEYPartner
iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY
Horizon Europe · 2026–2031 · Project on CORDIS ↗
€132ktheir share - CERTAINTYPartner
A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€102ktheir share - ASCERTAINPartner
Affordability and Sustainability improvements by using new pricing, Cost-Effectiveness and ReimbursemenT models to Appraise iNnovative health technologies
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€225ktheir share - SISAQOL-IMIPartner
Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
- CARAMBAPartner
SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€116ktheir share - MMpredictPartner
Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients
Horizon 2020 · 2016–2020 · Project on CORDIS ↗
€49ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Erasmus Universiteit RotterdamNetherlands · 2 shared projects
- Universitaetsklinikum Wuerzburg - Klinikum der Bayerischen Julius-Maximilians-UniversitatGermany · 2 shared projects
- Bundesinstitut Fur Impfstoffe und Biomedizinische ArzneimittelGermany · 2 shared projects
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 1 shared project
- Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 1 shared project
- Katholieke Universiteit LeuvenBelgium · 1 shared project
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
- Universiteit GentBelgium · 1 shared project
- Universitetet i OsloNorway · 1 shared project
- Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
- The University of BirminghamUnited Kingdom · 1 shared project
- University of LeedsUnited Kingdom · 1 shared project
- Charite - Universitaetsmedizin BerlinGermany · 1 shared project
- Academisch Ziekenhuis LeidenNetherlands · 1 shared project
- Stichting Amsterdam UmcNetherlands · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- cells technologies
- ecosystems
- entrepreneurship
- gene therapy
- hematology
- immunology
- immunotherapy
- leukemia
- oncology
- personalized medicine
- pharmaceutical drugs
- software development
- transcriptomes
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
